Autoimmune Hemolytic Anemia After mRNA COVID Vaccine

Creator(s)

Zainab Fatima, East Tennessee State UniversityFollow
Blair R. Reece, East Tennessee State UniversityFollow
J S. Moore, East Tennessee State University
Robert T. Means, East Tennessee State University, Johnson City, USA.Follow

Document Type

Article

Publication Date

1-1-2022

Description

Discussion of the hematologic complications of vaccination for severe acute respiratory syndrome coronavirus-2 (COVID-19) has primarily focused on the development of vaccine-associated immune thrombosis with thrombocytopenia (VITT). Other hematologic complications are uncommon. We report the case of a patient who developed immunoglobulin G (IgG)-mediated autoimmune hemolytic anemia (AIHA) after the Moderna COVID-19 messenger ribonucleic acid (mRNA) vaccine.

Citation Information

Fatima, Zainab; Reece, Blair R.; Moore, J S.; and Means, Robert T., "Autoimmune Hemolytic Anemia After mRNA COVID Vaccine" (2022). ETSU Faculty Works. 143.
https://dc.etsu.edu/etsu-works-2/143